• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer

    2023-12-09 08:17:02XiaorongFuYiZhangQingLuoYangJuGuanbinSong
    Cancer Biology & Medicine 2023年11期

    Xiaorong Fu, Yi Zhang, Qing Luo, Yang Ju, Guanbin Song

    1School of Biology and Engineering, Guizhou Medical University, Guiyang 550000, China; 2College of Bioengineering,Chongqing University, Chongqing 400030, China; 3Department of Mechanical Science and Engineering, Nagoya University,Nagoya 4648603, Japan

    ABSTRACT Over the past 2 decades, cancer stem cells (CSCs) have been identified as the root cause of cancer occurrence, progression,chemoradioresistance, recurrence, and metastasis.Targeting CSCs is a novel therapeutic strategy for cancer management and treatment.Liver cancer (LC) is a malignant disease that can endanger human health.Studies are increasingly suggesting that changes in the liver mechanical microenvironment are a primary driver triggering the occurrence and development of liver cancer.In this review, we summarize current understanding of the roles of the liver mechano-microenvironment and liver cancer stem cells(LCSCs) in liver cancer progression.We also discuss the relationship between the mechanical heterogeneity of liver cancer tissues and LCSC recruitment and metastasis.Finally, we highlight potential mechanosensitive molecules in LCSCs and mechanotherapy in liver cancer.Understanding the roles and regulatory mechanisms of the mechano-microenvironment and LCSCs may provide fundamental insights into liver cancer progression and aid in further development of novel therapeutic strategies.

    KEYWORDS Liver cancer; mechano-microenvironment; cancer stem cells; tumor heterogeneity; mechanotherapy

    Introduction

    Cancer is a major health-threatening disease and is the second leading cause of death worldwide1,2.Globally, liver cancer is among the most common cancers: approximately 900,000 new cases and more than 830,000 new deaths occurred in 2020,according to GLOBOCAN 2020, and liver cancer has become the second leading cause of cancer-related deaths after lung cancer1,3.In China, the incidence and mortality rate associated with liver cancer are high.Approximately 431,383 new liver cancer cases, and approximately 412,216 new deaths were estimated to have occurred in China in 2022, accounting for approximately half of all new liver cancer patients and deaths worldwide1,4.Poor treatment efficacy, high rates of recurrence and metastasis, and low survival rates of liver cancer pose a heavy economic burden on families and society.Therefore,exploring effective new methods to treat liver cancer remains a major challenge for clinical experts.

    The liver, performs several important functions and has a remarkable ability to regenerate itself.However, illnesses can cause permanent and irreversible liver damage.Liver tissue mechanical properties substantially change during pathogenesis.Tissue stiffness increases from normal liver tissue to fibrotic liver tissue, cirrhotic liver tissue, and hepatocellular carcinoma(HCC) liver tissue; the stiffness of cancerous liver tissue is approximately 10-fold higher than that of normal liver tissue5-8.In addition, liver cancer tissue shows mechanical heterogeneity,wherein the core is softest, the greatest stiffness is observed at the invasive external edges, and the middle region has intermediate stiffness6.Studies are increasingly suggesting that changes in the liver mechanical microenvironment during liver tissue pathogenesis are a primary driver triggering the occurrence and development of liver cancer9-11.

    Recently, a small subpopulation of cells sharing features with somatic stem cells, referred to as cancer stem cells (CSCs),have been identified in most tumors and demonstrated to be the root cause of cancer occurrence, progression, chemoradioresistance, recurrence, and metastasis12.Liver cancer stem cells (LCSCs) are responsible for tumor growth, recurrence,and metastasis in HCC, as well as failure of chemotherapy and radiotherapy13.Targeting liver LCSCs may be an emerging approach for diagnosing and treating liver cancer.Therefore,in this review, we discuss the crucial roles of the liver mechano- microenvironment and LCSCs in the progression of liver cancer, and the relationship between the mechanomicroenvironment and LCSCs, to provide insights into new therapeutic approaches.

    The mechanical microenvironment and liver cancer progression

    A healthy liver comprises 2 main lobes, consisting of 8 segments and thousands of lobules.These lobules are connected to small ducts, which in turn are connected to larger ducts forming a common hepatic duct.Blood flows through the larger ducts to the small ducts, and then to the lobules, which consist primarily of hepatocytes and sinusoids.The sinusoid is a discontinuous capillary whose caliber is larger than that of other capillaries, and it has a lining of specialized endothelial cells called liver sinusoidal endothelial cells (LSECs).Kupffer cells are present in the sinusoids and have clearance functions14,15.The space of Disse between the hepatocytes and sinusoids contains a low density of extracellular matrix (ECM)and quiescent hepatic stellate cells (HSCs)16.

    The liver performs vital functions such as synthesis, nutrient processing, and detoxification, and liver failure is a critical health threat.Hepatitis is a common liver disease, and many patients with liver cancer progress sequentially from the onset of chronic liver diseases such as hepatitis, fibrosis, cirrhosis, and HCC17.Furthermore, tissue stiffness increases from normal liver tissue to liver fibrosis, cirrhosis, and HCC; the stiffness of liver cancer tissue has been reported to be approximately 10-fold that of normal tissue5-8.Increased cancer cell density and size are among the most important contributors to the enhanced stiffness in HCC tissue.In this section,we describe the relationship between mechanical changes in liver disease and the development of liver cancer, as well as the mechanical heterogeneity of the liver intratumor tissue.

    Changes in mechanical properties during liver tissue canceration

    Chronic liver diseases, such as chronic viral hepatitis caused by hepatitis B or C viral infection, metabolic dysfunctionassociated steatotic liver disease, and alcoholic liver disease, can damage the liver.The development of liver fibrosis is based on chronic, recurrent, and persistent liver damage, and is a pathological phenomenon that occurs during the wound-healing response to liver tissue damage.During this process, collagen,glycoproteins, proteoglycans, and other ECM molecules are overproduced and abnormally distributed in the liver; the rate of production exceeds the rate of degradation, thereby resulting in ECM deposition and causing abnormalities in liver structure and function18,19, and consequently contributing to liver stiffening.Liver fibrosis is a pre-cirrhotic lesion that serves as the basis for cirrhosis development.

    According to the METAVIR classification system, liver fibrosis can be classified into 4 stages: F0-F1 (absent or mild fibrosis), F2 (significant fibrosis), F3 (severe fibrosis), and F4 (cirrhosis)5.Stiffness gradually increases from normal liver tissues to multi-stage liver fibrosis, liver cirrhosis, and HCC5.Liver stiffness, measured with ultrasound-based transient elastography (Fibroscan technique) ranges from 2.5 to 7 kPa in the F0 to F1 stage, to 7.1 kPa in the F2 stage, 9.5 kPa in the F3 stage, and 12.5 to 75.5 kPa in the F4 stage8.The highest degree of liver cirrhosis can reach 75.5 kPa, similar to the range of liver cancer tissue stiffness7.The liver tumor stiffness, measured with ultrasound transient elastography, is 55 kPa in HCC, 75 kPa in cholangiocellular carcinoma, and 66.5 kPa in metastatic tumors7.Mueller et al.20have also used ultrasound transient elastography to measure liver stiffness and have concluded that the stiffness of normal liver tissue is below 6 kPa, that of F3 fibrosis is 8 kPa, and that of F4 fibrosis (cirrhosis) is 12.5 kPa.Tatsumi et al.10have analyzed 1,002 cases (246 with HCC and 756 without HCC) and investigated the fibrotic stage at which the risk of HCC development increases; they have reported that liver stiffness > 12.0 kPa is an independent risk factor for HCC development.A recent study has indicated that stiffness > 30 kPa (detectedviatransient elastography) is a significant adverse predictor of survival in patients with advanced HCC21.Transient elastography has been reported to have several limitations22,23.Currently, atomic force microscopy (AFM) is used to detect liver tissue stiffness.Transient elastography can measure only the bulk stiffness of targeted tissue, whereas AFM can measure local tissue stiffness quantitatively.Normal liver tissue stiffness, as detected by AFM, is approximately 150 Pa, whereas in fibrotic liver tissue, the stiffness ranges from 1 to 6 kPa24.Sun et al.6have used N-nitrosomorpholine to stimulate the development of hepatitis, fibrosis, early stage cirrhosis, late-stage cirrhosis, and HCC, and measured the stiffness of each group by AFM.The stiffness of control samples (normal liver tissue) was 0.113 kPa; that in the hepatitis group without collagen proliferation was 0.19 kPa; that in the liver fibrosis group increased to 0.245 kPa; that in the early- cirrhotic group increased to 0.344 kPa; that in the late-cirrhotic group significantly increased to 0.79 kPa; and that in the HCC group reached 1.65 kPa6.The above findings indicate that both transient elastography (Figure 1) and AFM measurements show an increasing trend of stiffness from normal liver tissue to fibrous liver tissue and finally to liver cirrhosis/liver cancer tissue (Table 1).

    A direct relationship exists between cirrhosis and the development of liver cancer.Cirrhosis is the main cause of precancerous lesions of liver cancer.Reports have indicated that 80%-90% of HCC cases occur because of liver cirrhosis25,26,and liver cirrhosis is a unifying risk factor for the progression of HCC9-11.Liver cancer tissue is approximately 10-fold stiffer than normal liver tissue5-8.Therefore, investigating the relationship between the changing stiffness under liver pathological processes and the progression of liver cancer may be an emerging approach for improving understanding of liver cancer biology and cure (Figure 2A-2C).

    Mechanical heterogeneity of liver cancer tissue

    The heterogeneity of liver cancer poses serious challenges for developing and controlling systemic therapies.Liver cancer displays mechanical, cellular, molecular, and metabolic heterogeneity.In this section, we discuss the mechanical heterogeneity of liver cancer tissues (Figure 2C, 2D).The stiffness of liver tissue in different intratumor regions varies.In liver cancer tissues, the core part of the tumor is softest, the invasive front tissue is stiffest, and the middle part has intermediate stiffness6,27,28.Breast intratumor tissues have also been reported to exhibit mechanical heterogeneity.The core area of the breast intratumor tissue is softest, the middle area has intermediate stiffness, and the invasive peripheral area is stiffest29,30.Both liver and breast intratumor regions show mechanical heterogeneity.However, only a few reports on mechanical heterogeneity in the intratumor regions of other types of cancer tissues have been published.Further studies are required to determine the mechanical heterogeneity of cancerous tissues.

    Figure 1 Pathological changes in liver tissue stiffness, detected by ultrasound transient elastography.The tissue stiffness increases from normal liver tissue to liver fibrosis and cirrhosis.The stiffness of normal liver tissue is below 6 kPa20.The stiffness of the non-cirrhotic stage of fibrosis (F1-F3) is 7-9.5 kPa8.The stiffness of F4 fibrosis (cirrhosis) is > 12.5 kPa20.The range of liver cirrhosis stiffness is similar to that of liver cancer tissue.Liver stiffness > 12.0 kPa is an independent risk factor for new HCC development10.Liver cancer tissue > 30 kPa is a significant adverse predictor of survival in patients with advanced HCC21.

    Table 1 Pathological changes in liver tissue stiffness

    Figure 2 The mechanical microenvironment of the liver is closely associated with pathological changes in the liver.(A) Hepatocytes and LSECs are separated by the space of Disse, which contains minimal ECM in healthy liver tissue.Quiescent HSCs reside in the space of Disse.Kupffer cells exist in the sinusoid.(B) In liver fibrosis/cirrhosis, HSCs are activated and contribute to the production and deposition of ECM, thereby contributing to stiffening.(C) Liver cirrhosis with elevated stiffness is strongly associated with the development of liver cancer.Quiescent HSCs and other cell types are transformed into CAFs, which produce large amounts of ECM deposition around liver tumors.ECM deposition and vascular penetration contribute to increased stiffness and mechanical heterogeneity in liver tumors.(D) Liver cancer tissue displays mechanical heterogeneity, gradually increasing in stiffness from the core to the invasive periphery.

    Understanding the reason for the mechanical heterogeneity of liver cancer tissues is essential for improving understanding of cancer biology.The rapid proliferation of liver cancer cells results in the formation of liver cancer tissues consisting of a core region of cancer cells and an invasive front region(Figure 2D).A recent study has identified and characterized a 500 μm-wide invasive zone centered on the tumor border in liver cancer, which was defined as the region within 250 μm on both sides (tumor tissue side and paratumor tissue side) of the tumor margin areas (the border); enrichment of fibroblasts on the tumor side of the border compared with the paratumor side has been observed31.Highly activated fibroblasts in metastatic cancer increase stiffness and are a major source of cancer-associated fibroblasts (CAFs)32.CAFs, the principal producers of ECM in solid tumors33,34, lead to substantial deposition of ECM surrounding tumors (Figure 2C).The specific microenvironment of cancer tissues also stimulates quiescent HSCs to activate CAFs35.Furthermore,studies have shown that CAFs express lysyl oxidase (LOX),thereby initiating collagen crosslinking36,37.The abundant deposition of ECM and crosslinking at the external invasion site increases ECM stiffness, which in turn enhances cancer cell tension27,38in the invasive front of liver cancer tissues.However, ECM deposition gradually decreases from the invasive front to the core6.Therefore, outside the invasive front of cancer tissue, ECM deposition is affected by compressive pressure resulting from the spatial occupancy effect of the rapidly proliferating cancer cells and the massive deposition of ECM.Simultaneously, ECM crosslinking further increases ECM stiffness, and the cell-ECM connections and ECM stiffening increase the cell tension27,39.Furthermore, cancer tissue located at the invasive front is constrained by the surrounding normal tissue, and consequently is subjected to the stretching force of normal tissues.However, the cancer tissue core is affected primarily by compressive pressure resulting from the spatial occupancy effect of the rapid proliferation of cancer cells.All the above mechanical regimes together contribute to greater solid stress at the invasive front of cancer tissues than at the core; consequently, the invasive front is much stiffer than the core.

    In addition, vascular permeability in cancer tissues squeezes the surrounding tissues (Figure 2C) and indirectly increases cancer tissue stiffness.High vascular permeability is key in increasing interstitial fluid pressure (IFP)40,41.Intravascular fluid and solutes leave the capillaries under blood pressure and enter the interstitial microenvironment of cancer tissues,thereby increasing hydrostatic interstitial fluid pressure38.The external parts of tumors are more vascularized, whereas the internal supply of oxygen and nutrients becomes insufficient because of a lack of blood vessel distribution, thus leading to internal cancer cell necrosis42,43.Necrosis at the core of HCC, which generally occurs with tumor growth, is an important reason for the lower stiffness in the core of HCC44.Lower vascular distribution may be another reason for the lower internal stiffness than the external marginal stiffness of cancer tissue.Mechanical heterogeneity at different sites in cancer tissue may lead to heterogeneity in cellular functions.The mechanical heterogeneity of liver cancer tissue, and its influence on cancer cell behavior, warrants further in-depth study.

    In summary, pathological mechanical changes in liver tissue play important roles in the occurrence and development of liver cancer (Figure 2A-2C).In addition, liver intratumor regions display mechanical heterogeneity (Figure 2D).Targeting the mechanical microenvironment may enable breakthroughs in the understanding and treatment of liver cancer.

    LCSCs and liver cancer progression

    Studies are increasingly indicating that, in liver cancer cells,a small subpopulation of cell types, named LCSCs, have the capacity for self-renewal, chemotherapy resistance, recurrence,and metastasis13.Furthermore, the distribution and stemness of LCSCs are affected by the mechanical heterogeneity of the liver intratumor region6.In this section, we focus on the roles of LCSCs in the progression and metastasis of liver cancer, and on how the mechanical heterogeneity of the liver intratumor region influences LCSC distribution, stemness, and function(Figures 3 and 4).

    Figure 3 Potential origin and heterogeneity of LCSCs.LCSCs may originate from non-LCSCs that undergo dedifferentiation and share many similar characteristics with normal stem cells.LCSC heterogeneity in different subpopulations is identified by the expression of various LCSC markers.Different LCSC subpopulations are independently associated with the prognosis of HCC and contribute to intratumor heterogeneity and tumor progression.

    Characteristics of LCSCs

    The liver is a unique organ exhibiting remarkable plasticity and regenerative potential after injury.Liver regeneration may involve the activation of fully differentiated hepatocytes or liver stem/progenitor cells.Hepatocytes are responsible primarily for maintaining the liver under normal conditions and responding to acute liver injury.In severe liver diseases, such as hepatitis and liver fibrosis/cirrhosis, hepatocyte replication potential is impaired, and liver stem/progenitor cells can be activated to supply new hepatocytes and maintain the functional integrity of the liver45.Hepatocytes are the cells of origin in HCC46.Transformed hepatocytes can also activate liver stem/progenitor cell proliferation and promote tumor heterogeneity during the early stages of HCC47.In addition, liver cancer progenitor cells exist in precancerous areas and contain foci of mutated hepatocytes showing CSC-like features; therefore, liver cancer progenitor cells are considered the precursors of LCSCs48.Many LCSC markers found in HCC are oncofetal markers shared by hepatoblasts and liver stem/progenitor cells47.LCSCs have been inferred to originate from liver stem/progenitor cells,because they share many characteristics with normal stem cells.Furthermore, LCSCs are highly plastic.Transformed markernegative liver cancer cells can acquire features of LCSCs, which in turn can differentiate into normal liver cancer cells49-51.Therefore, improved understanding of LCSC plasticity may help develop new LCSC-targeted therapies.

    Various cell surface markers have been used to identify LCSCs in liver cancer.Nearly 20 molecular markers have been identified to isolate and characterize LCSCs52.Other studies have summarized LCSC surface markers in detail13,52-55.Surface markers, such as CD13, CD44, EpCAM, CD90, CD24,CD34, CD47, ICAM1, EpCAM, LGR5, and OV6, are widely recognized as markers of LCSCs, because of their association with proliferative capacity, self-renewal capacity, drug resistance, and recurrence of liver cancer.However, no specific markers specifically identify LCSCs, and simultaneous expression of more markers in LCSCs has been associated with greater stemness56.For example, the CD133+/ALDH+subgroup of LCSCs displays stronger tumorigenicity than the CD133-/ALDH+, CD133+/ALDH-, or CD133-/ALDH-subgroup of LCSCs, bothin vivoandin vitro57,58.The CD133+/EpCAM+subgroup of LCSCs shows higher tumor-initiating activity than the CD133+/EpCAM-and CD133-/EpCAM+subgroups of LCSCs59.LCSC heterogeneity in different subgroups is identifiedviaexpressed LCSC markers56.Different LCSC subgroups are independently associated with HCC prognosis and contribute to intratumor heterogeneity and tumor progression60.LCSC subgroups identified with single-cell surface markers have higher self-renewal ability than marker-negative cells, but LCSCs identified with different single-cell surface markers and different numbers of single-cell surface markers display appreciable biological differences56.LCSCs, defined by various cell surface markers, may contain different oncogenic drivers, thus posing challenges in identifying targeted therapeutic approaches.Because many markers have been discovered for LCSCs, and the antibody cost and time required can be substantial, many studies usually select only one or several markers as criteria to screen cell subpopulations of LCSCs.However, whether the undetected markers might affect the molecular mechanism of the detected marker-associated signaling pathways is unclear.Furthermore,comprehensive studies of different markers to discover their differences and associations in the regulation of liver cancer metastasis are lacking.In addition, whether new markers might better represent the LCSC subpopulation warrants further exploration (Figure 3).

    Implications of mechanical heterogeneity,LCSCs, and epithelial-mesenchymal transition(EMT)

    As discussed above, both liver and breast cancer tissues show mechanical heterogeneity, wherein the invasive front is stiffest,and the core is softest.A recent study has indicated that the distribution of LCSCs is closely associated with the mechanical heterogeneity of liver cancer (Figure 4).Sun et al.6have demonstrated that the greatest number of LCSCs (EPCAM+,CD13+, and CD44+) is found in the stiffer invasive front of the liver cancer tissue in a rat liver cancer model, thus indicating that stiffer liver cancer tissue (marginal part) is more suitable for potentiating the stemness of LCSCs.CSCs in breast cancer and glioma also have similar heterogeneity in distribution.CD24-CD44+BCSCs are localized at the tumor-invasive front, whereas ALDH-expressing BCSCs are located more centrally61.In addition, glioma stem cells are preferentially located at the stiffer invasive front rather than at the softer intratumor core62.These findings suggest that the stemness maintenance of CSCs is location-dependent within cancerous tissues and is likely to be affected by the mechanical heterogeneity of cancer tissues.A stiffer invasive front may favor the distribution of CSCs because the mechanical microenvironment of the invasive front is more suitable for stemness maintenance and functions of CSCs.

    EMT refers to epithelial cells that lose cell-to-cell connections, undergoes cytoskeletal remodeling leading to loss of polarity, and finally acquires a mesenchymal phenotype63.Furthermore, EMT is reversible, and the epithelial phenotype produced by mesenchymal- epithelial transformation (MET) is characterized by E-cadherin expression and the establishment of cell polarity.Cancer cells undergoing EMT have aggressive properties, such as metastasis, invasion, immune suppression,and drug resistance.Emerging studies indicate that EMT is an important contributor to CSC function in many cancer types, including liver cancer64-67.Cancer cells undergoing EMT have been reported to possess many stem cell-like features, such as elevated CD44 expression and enhanced ability to form spheroids68.CD24-CD44+BCSCs are primarily quiescent and exhibit EMT phenotypes, whereas ALDH-expressing BCSCs are proliferative and exhibit the MET phenotype61.In squamous cell carcinoma, CSCs termed CD44highESAlowhave been found to be migratory and to have mesenchymal traits characteristic of EMT CSCs.In contrast, CSCs termed CD44highESAhighare proliferative and retain epithelial characteristics (MET CSCs)64.CSCs associated with invasion and migration abilities have been associated with EMT, whereas CSCs associated with proliferation have been associated with MET.Furthermore, a study has revealed that EMT preferentially occurs in the stiffer invasive front of breast tumors in humans and mice29.Interestingly, CSCs are also preferentially located at the invasive front of tumors6,61,69.Therefore, the stiffer mechanical microenvironment of the invasive front may facilitate CSC EMT and consequently result in cancer tissue invasion, dissemination, and growth at metastatic sites (Figure 4).However, studies on the relationships among cancer tissue mechanical heterogeneity, CSC distribution, and EMT are lacking.Further studies focusing on this aspect may enhance understanding of the mechanical heterogeneity of cancer and CSC biology.

    Liver cancer therapy targeting the mechanical microenvironment and LCSCs

    The human body is continually exposed to various physical forces.These physical forces are called mechanotherapy in the context of rehabilitation and therapeutic outcomes70.Mechanotherapy was first defined in the Oxford English Dictionary in 1890 as “the treatment of disease by mechanical means”.Mechanotherapy is currently used as a physical therapy.Traditional physical therapy focuses primarily on rehabilitation, namely exercise therapeutics for injured tissues of patients recovering from trauma or surgery.Recent developments in mechanobiology have shed light on the effects of physical forces on cells and tissues71.Cells can be exposed to various micromechanical stimuli, including tension, compression, shear stress, and hydrostatic pressure, all of which affect their functions.However, mechanotherapy is seldom used as a therapeutic intervention for specific diseases such as cancer.Solid cancer tissue is typically much stiffer than the surrounding healthy tissues.In particular, liver cancer tissues usually present mechanical heterogeneity.Therefore, the use of mechanotherapy to explore how cancer cells in liver cancer tissue are affected by the mechanical microenvironment, as well as treatment of liver cancer through mechanical means, may greatly aid in improving the therapeutic approach for liver cancer.Moreover, the distribution and maintenance of LCSC stemness, which plays important roles in the progression and metastasis of liver cancer, are influenced by the mechanical heterogeneity of liver cancer tissues6.Therefore, in this section, we focus on the importance of targeting the mechanical microenvironment and LCSCs to improve liver cancer treatment (Figure 5).

    Targeting the liver cancer mechanical microenvironment

    Targeting the ECM

    Figure 5 Liver cancer therapy targeting the mechanical microenvironment and LCSCs.The increased cancer cell density, ECM deposition and crosslinking, increased vascular permeability and IFP, and necrosis in the core of liver cancer tissue contribute to the mechanical heterogeneity of liver cancer tissue.Common HCC therapeutic strategies, such as TACE and immunotherapy, are associated with tumor stiffness.The distribution of LCSCs in liver cancer tissue is affected by the mechanical heterogeneity of liver cancer tissue.Increased matrix stiffness contributes to LCSC stemness maintenance.Focusing on the mechanical microenvironment and LCSCs in liver carcinogenesis may provide theoretical guidance for preventing and treating liver cancer in clinical settings.

    In the liver tumor tissue microenvironment, with the rapid proliferation of cancer cells, an increase in the number of non-cancer cells, and overproduction and structural remodeling of the ECM, the tumor microenvironment (TME) density gradually increases and enhances stiffness.In addition, vascular penetration contributes to increased stiffness.ECM stiffening upregulates exosome secretion, which in turn leads to changes in the TME that promote tumor growth72.Increased matrix stiffness induces upregulation of Piezo1, which restrains ubiquitination of the hypoxia-inducible factor-1α (HIF-1α) and subsequently enhances the expression of downstream pro-angiogenic factors, thereby accelerating HCC angiogenesis73.Therefore,blocking ECM deposition and angiogenesis can downregulate tumor stiffening.CAFs are the primary donors of massive ECM deposition around tumors33,34, and ECM stiffening contributes to angiogenesis74.One study has indicated that downregulating liver metastasis stiffness by inhibiting the activity of metastasis-associated fibroblasts with renin-angiotensin system (anti-RAS) inhibitors decreases ECM stiffness, which in turn increases the anti-angiogenic effects of bevacizumab in patients with metastatic colorectal cancer74.The main components of the ECM are collagen and matrix metalloproteinases(MMPs), which are enzymes that specifically degrade collagen.One study has cultured HCC cells in a collagen-based gel tailored with an elastic modulus of ≈4.0 kPa.Subsequently, the gel was treated with MMP-1 to decrease the elastic modulus from 4.0 to 0.5 kPa, thus resulting in greater HCC cell sensitivity to radiation than observed in cells grown on stiffer gel not exposed to MMP-1 treatment75.

    Targeting the IFP

    The IFP in most solid tumors is significantly higher than that in normal tissues41,76.Increased IFP in tumors forms a

    physiological barrier to drug delivery77.In a rabbit liver tumor model, the downregulation of IFP levels has been found to increase drug penetration into liver tumors78.High vascular permeability has been reported to be key in increasing IFP40,41.Inhibiting vascular permeability decreases IFP and upregulates anticancer drug delivery to tumors79.Furthermore,nanosystems loaded with anticancer drugs modified with cell-penetrating peptides readily penetrate tumor masses.Cell-penetrating peptides have high tissue penetration ability and low cytotoxicity, thereby overcoming the problems of low delivery efficiency and limited tumor-penetrating ability of drug carriers.Chen et al.80have found that a cell-penetrating peptide (tLyP-1)-conjugated ZIF-90 nanosystem loaded with anticancer drugs penetrates the liver tumor mass with the help of tLyP-1, and can eradicate differentiated liver cancer cells and LCSCs simultaneously.The lipid-modified cell- penetrating peptide aggregates into micelles and enables simultaneous loading of the natural product narciclasine and ULK1 siRNA,which target HCC by synergistically inhibiting autophagy and inducing apoptosis81.

    Liver cancer tissue stiffness and common HCC therapeutic strategies

    Transarterial chemoembolization (TACE) indicates that chemotherapy drugs can be transported to local liver tumors through the blood vessels; simultaneously, the tumor’s blood vessels can be blocked with iodized oil, polyvinyl alcohol particles,or drug-loaded microspheres, thus decreasing or even cutting off the nutrient supply to tumors, and shrinking tumor size, delaying tumor progression, and extending survival time.TACE aggravates fibrosis and increases the stiffness of liver cancer tissues within short time periods82,83.Haas et al.84have demonstrated that the size of liver tumors decreases after treatment with TACE, but the stiffness increases.Praktjknjo et al.85have also shown greater stiffness in liver cancer tissue 3 days after TACE treatment than in non-treated liver cancer tissue.Hou et al.86have analyzed 230 patients who underwent TACE and found that the tumor stiffness increased from 40.1 kPa(before TACE) to 60.4 kPa (after TACE), whereas 1 month after TACE, the stiffness decreased to 19.3 kPa.These results suggest that TACE therapy affects the mechanical microenvironment of liver cancer tissue, and decreased tumor size and increased tumor stiffness (during short time periods) are considered good responses86.

    Tumor immunotherapy, one of the most successful methods in cancer therapy in recent years, is divided primarily into 2 types: cellular immunotherapy and immune checkpoint inhibitor (ICI) therapy.Cellular immunotherapy refers to collecting immune cells from the patient’s body and modifying them outside the body to achieve more effective and accurate immune activity against cancer cells.After the modified immune cells are injected back into the patient’s body, they are directed to kill cancer cells.Immune cells (such as T cells,B cells, dendritic cells, and mononuclear macrophages) are the primary cellular components of the tumor immune microenvironment87.The use of T-cells to specifically recognize and kill cancer cells has become a commonly topic in immunebased cancer therapies.However, in most immunotherapies for solid tumors, T cells are gradually depleted88.The TME is the main factor affecting normal T cell function89.Although most immune cells are suspension cells that exist in blood vessels, they must infiltrate the TME to kill tumor cells.Immune cells are inevitably affected by the mechanical microenvironment of tumors.Study has shown that the hardness of tumor tissues prevents immune cells from penetrating the TME90.Liu et al.91have analyzed existing single-cell tumor sequencing results and found significant differences in gene expression in T cells from tumors, healthy tissues, and blood vessels.When T cells are exposed to collagen environments with high viscoelasticity, they tend to become memory T cells capable of killing tumor cells and display greater tumor size control in mice91.

    ICI therapy involves immune cells that produce small protein molecules that inhibit their own functions.Tumor cells use this mechanism to suppress immune cells and survive by escaping the immune system.ICI eliminate this immune tolerance and allow immune cells to reactivate and kill cancer cells.

    However, the unique mechanical microenvironment of tumors is a major obstacle to ICI therapy.Tumor stiffening and solid stress elevation induce hypoperfusion and hypoxia by compressing tumor vessels92.Hypoperfusion and a stiff TME are physical barriers to T-cell infiltration into tumors93, whereas higher perfusion levels increase ICI therapy efficacy94,95.Downregulation of tumor stiffness has been found to enhance perfusion and ICI efficacy92.These results suggest that common HCC therapeutic strategies such as TACE and immunotherapy are closely associated with the tumor mechanical microenvironment.The mechanical microenvironment is a non-negligible factor in HCC treatment.

    Targeting LCSCs

    Targeting oncogenes or oncoproteins and essential signaling pathways

    LCSCs are believed to be at the origin of tumor recurrence,resistance, and metastasis.Therefore, drugs specifically targeting LCSCs must be developed96.Furthermore, stemness maintenance and functions of LCSCs are associated with oncogenes, oncoproteins, and signaling pathways.For example, YAP1 signaling initiated by long noncoding RNA drives the self-renewal and maintenance of CD13+CD133+LCSCs97.The TGF-β/H19 signaling axis, regulated by Sox2, in CD44+LCSCs is important in promoting hepatocarcinogenesis98.In a mouse model of HCC, tumors with co-activation of both Akt/mTOR and Wnt/β-catenin signaling pathways have been found to contain a subpopulation of SP/CD44+LCSCs,whose self-renewal and tumorigenesis are regulated by activated Stat3 pathways99.Src-homology 2 domain-containing phosphatase 2 (Shp2) facilitates LCSC (CD133+EpCAM+subgroup) expansion by promoting the dedifferentiation of hepatoma cells and enhancing the self-renewal of LCSCsviaamplifying β-catenin signaling51.The expression of inducible nitric oxide synthase in CD24+CD133+LCSCs, but not CD24-CD133-LCSCs, has been found to promote stemness characteristics of LCSCsviaNotch1 signaling, and to accelerate HCC initiation and tumor formation in a mouse xenograft tumor model100.LGR5+cells (LCSCs) are enriched in mouse liver tumors and are considered as an important LCSC subpopulation that contributes to organoid initiation, tumor formation, and chemotherapy resistance101.Lysine-specific demethylase 1 (LSD1) promotes activation of the β-catenin pathway, thereby maintaining the stemness and chemoresistance of the LGR5+subgroup of LCSCs101.Moreover, liver cancer and many other malignant cancers exhibit “aerobic glycolysis”102.However, increased oxidative phosphorylation is required for the stemness maintenance of LCSCs103.Wei et al.104have revealed that LCSCs rely on enhanced mitochondrial respiration to maintain their stemness properties, in contrast to aerobic glycolysis, which plays a major role in differentiating non-LCSCs.These findings indicate that LCSCs have unique properties from those of non-LCSCs.Therefore,targeting the unique properties of LCSCs, such as oncogenes,oncoproteins, and essential signaling pathways, may offer an effective approach to killing LCSCs and preventing liver cancer metastasis.

    Inducing differentiation of LCSCs and converting them into non-LCSCs

    Cyclin D1 has been reported to play an important role in tumorigenesis and metastasis in multiple cancers, including HCC.Silencing of cyclin D1 decreases the percentage of CD133+cells in HepG2 and SMMC-7721 cells, and overcomes 5-fluorouracil resistance105.In addition, because liver cancer cells are easily killed by anticancer drugs, inducing the differentiation of LCSCs and converting them into non-LCSCs may decrease the malignancy of liver cancer or inhibit its aggressiveness.Huang et al.49have revealed that LCSCs release exosomes in a RAB27A-dependent manner, thus inducing Nanog expression and regorafenib resistance in differentiated cells.Targeting this exosome signaling pathway blocks the conversion of non-LCSCs to LCSCs.

    Targeting the mechanical microenvironment of LCSCs in liver cancer tissue

    Because the maintenance and distribution of LCSCs are affected by the mechanical heterogeneity of liver cancer tissue, and the stiffer invasion front margin facilitates the distribution and maintenance of stemness of LCSCs to a greater extent than the soft core6, it has the potential to destroy the mechanical microenvironment of LCSCs in liver cancer tissue,thereby damaging to the mechanical microenvironment that maintains LCSC stemness and function.Manyin vitroexperiments have revealed that a stiffer matrix is conducive to maintaining LCSC stemness.For example, Li et al.69have cultured LCSCs in a 3D alginate matrix with different stiffness and found that a stiffer matrix (72.2 kPa), compared with a soft matrix (7.7 kPa), significantly potentiates LCSC stemness.Wei et al.106have collected surgical specimens from patients with HCC and detected the cross-section stiffness at different sites(core: 1.051 kPa; middle: 4.54 kPa; margin: 9.307 kPa) with AFM.The authors have designed a polyacrylamide hydrogel with a stiffness of 1.10 kPa, 4.47 kPa, and 10.61 kPa to simulate the effect of mechanical heterogeneity on HCCLM3 and Huh7 cell lines, and have found that the mRNA and protein levels of NANOG and OCT4 of LCSC markers increase with increasing hydrogel stiffness.Zhao et al.107have demonstrated that α2δ1+HCC TICs initiate ECM remodeling by secreting LOX,thus creating a stiff microenvironment with crosslinked collagen, which favors the acquisition and subsequent maintenance of the stem cell-like properties of α2δ1+TICs.Wang et al.108have demonstrated that liver tumor tissues from metastatic patients have higher matrix stiffness than the non-metastatic tissues, and matrix stiffness equips tumor cells with enhanced stemness and proliferative characteristics dependent on the activation of the integrin β1/FAK/ERK1/2/NF-κB signaling pathway.Yang et al.109have demonstrated that the cancer stem cell markers EpCAM, CD133, and ALDH-1 are elevated in Hep3B and Huh7 cellsviathe upregulation of CXCR4 expression, on stiff gels (12 kPa) compared with soft polyacrylamide hydrogels (1 kPa).These results indicate that the maintenance of LCSC stemness is affected by the mechanical cues of the matrix.Targeting the mechanical microenvironment of LCSCs in liver cancer tissues may provide a new strategy for the clinical treatment of liver cancer.

    Conclusion and perspectives

    The development of liver cancer is closely associated with changes in the liver mechanical microenvironment, and LCSCs promote the progression and metastasis of liver cancer.However, several challenges remain.First, the roles of mechanical factors in the development of liver cancer are not well understood or investigated.Second, research is lacking on the mechanical heterogeneity of liver cancer tissue that regulates the enrichment of LCSCs and the mechanism of malignant metastasis of liver cancer.Third, normal stem cell biology largely influences the current understanding of LCSCs: the current understanding of LCSCs greatly relies on normal stem cells and LCSCs sharing many of the same expression markers and activating self-renewal signaling pathways.LCSCs are removed by targeting these markers and signaling pathways; however, this process may also lead to the removal of normal liver stem/progenitor cells, thereby inhibiting liver regeneration and resulting in liver failure.Consequently, further research is needed to identify markers specific to LCSCs.Finally, the mechanical heterogeneity of liver cancer tissues considerably affects the distribution and maintenance of LCSC stemness.Disrupting the mechanical microenvironment of LCSCs may damage the microenvironment that LCSCs rely on to maintain their stemness and exert their functions, thus causing them to differentiate into non-LCSCs, and blocking the malignancy and metastasis of liver cancer.However, no effective strategy is currently available for targeting LCSCs on the basis of the mechanical heterogeneity of liver cancer tissues.

    In summary, the development of liver fibrosis, cirrhosis, and liver cancer and changes in the mechanical microenvironment of the liver tissue are closely associated with the development of liver cancer tissue.Furthermore, the distribution, stemness maintenance, and functions of LCSCs are associated with the mechanical heterogeneity of liver cancer tissues.Understanding the 2 key factors of the mechanical microenvironment and LCSCs in liver carcinogenesis may provide theoretical guidance for preventing and treating liver cancer in clinical settings.

    Acknowledgements

    We thank Dr.Guodong Wang (Nagoya University, Japan) for language review of the manuscript.

    Grant support

    This work was supported by grants from National Natural Science Foundation of China (Grant No.11832008), the Natural Science Foundation Project of Chongqing (Grant No.cstc2020jcyj-msxmX0545), and the Japan Society for the Promotion of Science under grants-in-Aid for Scientific Research (S) (Grant No.17H06146).

    Conflict of interest statement

    No potential conflicts of interest are disclosed.

    Author contributions

    Conceived and designed the analysis: Xiaorong Fu, Yang Ju,Guanbin Song.

    Collected the data: Xiaorong Fu, Yi Zhang, Qing Luo.

    Contributed data or analysis tools: Xiaorong Fu, Yi Zhang.Performed the analysis: Xiaorong Fu, Guanbin Song.Wrote the paper: Xiaorong Fu, Guanbin Song, Yang Ju.

    天堂av国产一区二区熟女人妻| 变态另类丝袜制服| 色综合亚洲欧美另类图片| 午夜亚洲福利在线播放| 亚洲人成电影免费在线| 国产在视频线在精品| 欧美乱色亚洲激情| 亚洲国产精品sss在线观看| 琪琪午夜伦伦电影理论片6080| 色精品久久人妻99蜜桃| 别揉我奶头 嗯啊视频| 亚洲欧美日韩东京热| 久久久久亚洲av毛片大全| 天堂动漫精品| 色精品久久人妻99蜜桃| 亚洲美女搞黄在线观看 | 在线看三级毛片| 99热精品在线国产| 国内少妇人妻偷人精品xxx网站| 国产精品免费一区二区三区在线| av视频在线观看入口| 欧美一区二区亚洲| 制服丝袜大香蕉在线| 国产欧美日韩一区二区精品| 一级作爱视频免费观看| 欧美黄色淫秽网站| 亚洲一区高清亚洲精品| 久久久久久久久中文| 每晚都被弄得嗷嗷叫到高潮| 亚洲国产欧美人成| 中文字幕精品亚洲无线码一区| 亚洲在线观看片| 久久香蕉精品热| 3wmmmm亚洲av在线观看| av视频在线观看入口| 一级av片app| 丁香六月欧美| 国产精品综合久久久久久久免费| 国产三级黄色录像| 国产中年淑女户外野战色| 啦啦啦韩国在线观看视频| 在线观看免费视频日本深夜| 欧美黑人欧美精品刺激| 午夜精品久久久久久毛片777| 久久国产精品人妻蜜桃| 亚洲第一区二区三区不卡| 国产蜜桃级精品一区二区三区| 欧美激情在线99| 如何舔出高潮| 欧美激情久久久久久爽电影| 国产真实乱freesex| 国产成人a区在线观看| h日本视频在线播放| 欧美bdsm另类| 中国美女看黄片| 日本三级黄在线观看| 伦理电影大哥的女人| 婷婷色综合大香蕉| 色精品久久人妻99蜜桃| 亚洲三级黄色毛片| 国产精品久久久久久亚洲av鲁大| 亚洲av日韩精品久久久久久密| 国产人妻一区二区三区在| 日韩大尺度精品在线看网址| 97碰自拍视频| 免费看美女性在线毛片视频| 欧美日韩亚洲国产一区二区在线观看| 在线a可以看的网站| 日本 av在线| 51午夜福利影视在线观看| 亚洲成a人片在线一区二区| netflix在线观看网站| ponron亚洲| 精品久久国产蜜桃| 国内精品久久久久久久电影| 婷婷亚洲欧美| 一二三四社区在线视频社区8| 淫秽高清视频在线观看| 欧美日韩亚洲国产一区二区在线观看| 97热精品久久久久久| 欧美成狂野欧美在线观看| 亚洲一区高清亚洲精品| 国产色爽女视频免费观看| 国产精品不卡视频一区二区 | 嫩草影院精品99| 俺也久久电影网| 成人鲁丝片一二三区免费| 又爽又黄a免费视频| 成人美女网站在线观看视频| 久久久久久久亚洲中文字幕 | 国产乱人视频| 亚洲国产欧洲综合997久久,| 99热6这里只有精品| 亚洲午夜理论影院| 在线观看一区二区三区| 成年人黄色毛片网站| 精品国内亚洲2022精品成人| 最好的美女福利视频网| 丝袜美腿在线中文| 亚洲欧美日韩高清在线视频| 婷婷精品国产亚洲av在线| 久久久精品欧美日韩精品| 亚洲成a人片在线一区二区| 亚洲va日本ⅴa欧美va伊人久久| eeuss影院久久| 免费搜索国产男女视频| 99精品在免费线老司机午夜| 亚洲 国产 在线| 国产精品自产拍在线观看55亚洲| 亚洲人成网站在线播| 国产老妇女一区| 五月玫瑰六月丁香| 99久久精品国产亚洲精品| 一本综合久久免费| 久久精品夜夜夜夜夜久久蜜豆| 亚洲五月天丁香| 午夜久久久久精精品| 国产精品久久久久久久电影| 国产一区二区亚洲精品在线观看| 国产视频内射| 国产精品亚洲一级av第二区| 舔av片在线| 又爽又黄无遮挡网站| 欧美绝顶高潮抽搐喷水| 国产精品,欧美在线| 真人一进一出gif抽搐免费| 国产欧美日韩精品一区二区| 3wmmmm亚洲av在线观看| av女优亚洲男人天堂| 成人精品一区二区免费| 搡女人真爽免费视频火全软件 | 国产免费av片在线观看野外av| 禁无遮挡网站| 9191精品国产免费久久| 美女免费视频网站| 十八禁人妻一区二区| 看免费av毛片| 亚洲成人中文字幕在线播放| 久久久国产成人免费| 午夜免费男女啪啪视频观看 | 一进一出抽搐gif免费好疼| 综合色av麻豆| 人妻久久中文字幕网| 国产精品亚洲一级av第二区| 美女xxoo啪啪120秒动态图 | 舔av片在线| 中文字幕免费在线视频6| 国产视频一区二区在线看| 床上黄色一级片| 性欧美人与动物交配| 精品福利观看| 色综合站精品国产| 亚洲国产精品久久男人天堂| 老熟妇仑乱视频hdxx| 免费观看人在逋| 日本三级黄在线观看| 两个人的视频大全免费| 天美传媒精品一区二区| 欧美最黄视频在线播放免费| 少妇被粗大猛烈的视频| 成人av在线播放网站| 在线观看舔阴道视频| 国产精品av视频在线免费观看| 日本一二三区视频观看| 国产在线男女| 色吧在线观看| 又爽又黄无遮挡网站| 午夜两性在线视频| 免费观看人在逋| 乱码一卡2卡4卡精品| 欧美+亚洲+日韩+国产| 久久6这里有精品| 国产aⅴ精品一区二区三区波| 日韩免费av在线播放| 一级毛片久久久久久久久女| 男女那种视频在线观看| 亚洲国产精品sss在线观看| 18禁裸乳无遮挡免费网站照片| 成人欧美大片| 久久婷婷人人爽人人干人人爱| 久9热在线精品视频| 欧美日本视频| 天堂√8在线中文| 又爽又黄无遮挡网站| 成人特级黄色片久久久久久久| 深爱激情五月婷婷| 亚洲男人的天堂狠狠| 国产午夜福利久久久久久| 欧美性感艳星| 淫妇啪啪啪对白视频| 亚洲精品一区av在线观看| 天天躁日日操中文字幕| 18+在线观看网站| 久久精品国产自在天天线| 亚洲最大成人手机在线| 成人高潮视频无遮挡免费网站| 亚洲熟妇中文字幕五十中出| 成年免费大片在线观看| 日本黄色视频三级网站网址| 天美传媒精品一区二区| 日韩大尺度精品在线看网址| 国产免费av片在线观看野外av| 亚洲人与动物交配视频| 国产毛片a区久久久久| 97超视频在线观看视频| 国产精品伦人一区二区| 99久久久亚洲精品蜜臀av| 一个人免费在线观看电影| 亚洲av成人精品一区久久| 自拍偷自拍亚洲精品老妇| 桃红色精品国产亚洲av| 在线十欧美十亚洲十日本专区| 美女黄网站色视频| 特大巨黑吊av在线直播| 国产高清视频在线播放一区| 日日干狠狠操夜夜爽| 欧美最黄视频在线播放免费| 亚洲综合色惰| 老司机福利观看| 国产精品综合久久久久久久免费| 18禁裸乳无遮挡免费网站照片| 久久久久免费精品人妻一区二区| 国产精品一区二区三区四区久久| 国产成人啪精品午夜网站| 国产精品综合久久久久久久免费| 久久午夜福利片| 成人精品一区二区免费| 十八禁网站免费在线| 久久草成人影院| 国内精品美女久久久久久| 国产黄色小视频在线观看| 看免费av毛片| 国产伦精品一区二区三区视频9| 亚洲成人久久爱视频| 久久国产精品影院| 欧美zozozo另类| 美女被艹到高潮喷水动态| 亚洲美女视频黄频| 国产精品亚洲av一区麻豆| 欧美三级亚洲精品| 免费搜索国产男女视频| 亚洲va日本ⅴa欧美va伊人久久| АⅤ资源中文在线天堂| 久久国产精品人妻蜜桃| 黄色女人牲交| 校园春色视频在线观看| 久久人人精品亚洲av| 免费观看的影片在线观看| 久久久久久久久久成人| 中文字幕熟女人妻在线| 精品国内亚洲2022精品成人| 亚州av有码| 久久草成人影院| 日韩免费av在线播放| 一边摸一边抽搐一进一小说| 国产成+人综合+亚洲专区| 国产av不卡久久| 人妻久久中文字幕网| 波多野结衣高清无吗| a在线观看视频网站| 成人永久免费在线观看视频| 色综合站精品国产| 国产又黄又爽又无遮挡在线| 久久亚洲精品不卡| 夜夜夜夜夜久久久久| 动漫黄色视频在线观看| 99riav亚洲国产免费| 欧美激情国产日韩精品一区| 淫秽高清视频在线观看| 国产伦精品一区二区三区四那| 日本与韩国留学比较| 亚洲欧美清纯卡通| 在线观看66精品国产| 俄罗斯特黄特色一大片| 亚洲午夜理论影院| 九九热线精品视视频播放| 欧美高清性xxxxhd video| 最好的美女福利视频网| 一级黄片播放器| 国产精品一区二区性色av| 免费搜索国产男女视频| 黄色一级大片看看| 亚洲七黄色美女视频| 欧美高清成人免费视频www| 美女黄网站色视频| 老师上课跳d突然被开到最大视频 久久午夜综合久久蜜桃 | 禁无遮挡网站| 日本成人三级电影网站| 国产精品久久久久久人妻精品电影| 久久久久久久久中文| www.999成人在线观看| 日韩欧美在线二视频| 人人妻,人人澡人人爽秒播| 久久九九热精品免费| 老熟妇乱子伦视频在线观看| 69人妻影院| 亚洲中文日韩欧美视频| 免费电影在线观看免费观看| www.熟女人妻精品国产| 久久精品夜夜夜夜夜久久蜜豆| 女人被狂操c到高潮| 国产高清视频在线播放一区| 欧美色视频一区免费| 黄色日韩在线| 亚洲欧美日韩卡通动漫| 人妻制服诱惑在线中文字幕| 我要搜黄色片| 熟妇人妻久久中文字幕3abv| 欧美性感艳星| 国产伦一二天堂av在线观看| 亚洲狠狠婷婷综合久久图片| 麻豆一二三区av精品| 亚洲熟妇中文字幕五十中出| 亚洲欧美日韩高清在线视频| 波多野结衣高清作品| 丰满人妻熟妇乱又伦精品不卡| 久久国产乱子免费精品| 欧美色欧美亚洲另类二区| 久久久久久九九精品二区国产| 毛片女人毛片| 亚洲 欧美 日韩 在线 免费| 国产成人影院久久av| 亚洲经典国产精华液单 | 一级黄色大片毛片| 一个人观看的视频www高清免费观看| 国产精品99久久久久久久久| 午夜亚洲福利在线播放| 国产午夜精品论理片| a级毛片a级免费在线| 国产欧美日韩精品一区二区| 亚洲国产欧美人成| 成人精品一区二区免费| 露出奶头的视频| a级一级毛片免费在线观看| 88av欧美| 亚洲av成人精品一区久久| 91麻豆精品激情在线观看国产| 亚洲精品乱码久久久v下载方式| 欧美在线黄色| 内地一区二区视频在线| av欧美777| 蜜桃亚洲精品一区二区三区| 3wmmmm亚洲av在线观看| 蜜桃久久精品国产亚洲av| 成人三级黄色视频| 色综合欧美亚洲国产小说| 自拍偷自拍亚洲精品老妇| 99热6这里只有精品| 亚洲 国产 在线| 能在线免费观看的黄片| 亚洲精品亚洲一区二区| x7x7x7水蜜桃| 免费看a级黄色片| 国产日本99.免费观看| 欧美又色又爽又黄视频| aaaaa片日本免费| 中文字幕av成人在线电影| 欧美日韩福利视频一区二区| 99在线人妻在线中文字幕| 久久久精品大字幕| 麻豆国产97在线/欧美| 日日夜夜操网爽| 亚洲熟妇中文字幕五十中出| 日日摸夜夜添夜夜添小说| 亚洲内射少妇av| 成人一区二区视频在线观看| 色哟哟·www| 免费一级毛片在线播放高清视频| 国产一区二区亚洲精品在线观看| 欧美高清成人免费视频www| 国产一区二区三区在线臀色熟女| 色5月婷婷丁香| 久久久精品欧美日韩精品| 欧美高清成人免费视频www| 淫秽高清视频在线观看| 国产伦一二天堂av在线观看| 岛国在线免费视频观看| av天堂中文字幕网| 十八禁人妻一区二区| 国产精品久久久久久久电影| 99在线视频只有这里精品首页| 国产午夜福利久久久久久| 午夜精品在线福利| 午夜福利高清视频| 国产成人av教育| 中文字幕av成人在线电影| 热99re8久久精品国产| 欧美又色又爽又黄视频| 国产精品伦人一区二区| 国产主播在线观看一区二区| 国产aⅴ精品一区二区三区波| 黄片小视频在线播放| 老司机午夜十八禁免费视频| 日本黄色视频三级网站网址| 亚洲av熟女| 成人亚洲精品av一区二区| 国产69精品久久久久777片| 欧美激情国产日韩精品一区| 丁香欧美五月| 中文字幕精品亚洲无线码一区| 成年女人看的毛片在线观看| 亚洲aⅴ乱码一区二区在线播放| 日韩欧美在线乱码| 色吧在线观看| 亚洲av电影不卡..在线观看| 午夜福利在线在线| 色精品久久人妻99蜜桃| 久久久久久久久中文| 亚洲av免费在线观看| 91麻豆av在线| 国内少妇人妻偷人精品xxx网站| 国产成人影院久久av| 成人高潮视频无遮挡免费网站| 国产精品日韩av在线免费观看| 国产久久久一区二区三区| 国产精品影院久久| 成年人黄色毛片网站| av福利片在线观看| 国产一区二区三区在线臀色熟女| 男女那种视频在线观看| 国产精品久久久久久亚洲av鲁大| 亚洲人与动物交配视频| 精品不卡国产一区二区三区| 极品教师在线免费播放| 最近最新中文字幕大全电影3| 亚洲中文字幕一区二区三区有码在线看| 国模一区二区三区四区视频| 国产亚洲精品综合一区在线观看| 97超视频在线观看视频| 在线看三级毛片| 亚洲精品在线观看二区| 国产成人影院久久av| 天天一区二区日本电影三级| 波多野结衣高清作品| 麻豆av噜噜一区二区三区| av天堂中文字幕网| 一夜夜www| 91在线观看av| 黄片小视频在线播放| 成熟少妇高潮喷水视频| 村上凉子中文字幕在线| 精品一区二区三区视频在线| 国产精品1区2区在线观看.| av在线天堂中文字幕| 成人欧美大片| 88av欧美| 丰满人妻熟妇乱又伦精品不卡| 久久人人精品亚洲av| 午夜激情福利司机影院| 亚洲人成网站在线播放欧美日韩| 俄罗斯特黄特色一大片| 免费av观看视频| 99热只有精品国产| 黄色丝袜av网址大全| 国产三级在线视频| 简卡轻食公司| 伦理电影大哥的女人| 亚洲五月天丁香| 久久久久久久久久成人| 国产一区二区三区在线臀色熟女| 淫妇啪啪啪对白视频| 国产精品乱码一区二三区的特点| 精品一区二区免费观看| 亚洲第一欧美日韩一区二区三区| 国产乱人视频| 亚洲成av人片免费观看| 欧美高清成人免费视频www| 国产一区二区在线av高清观看| 男女那种视频在线观看| 最新中文字幕久久久久| 色综合欧美亚洲国产小说| 久久久久亚洲av毛片大全| 一级作爱视频免费观看| 精品一区二区三区视频在线观看免费| 超碰av人人做人人爽久久| 国产伦在线观看视频一区| 欧美性感艳星| 日日摸夜夜添夜夜添小说| 男女床上黄色一级片免费看| 别揉我奶头 嗯啊视频| 色噜噜av男人的天堂激情| 又爽又黄无遮挡网站| 深夜a级毛片| 亚洲第一欧美日韩一区二区三区| 97碰自拍视频| 久久午夜亚洲精品久久| 小说图片视频综合网站| 啪啪无遮挡十八禁网站| 久久久久久久亚洲中文字幕 | 精品久久久久久久久av| 蜜桃久久精品国产亚洲av| 午夜a级毛片| 国产成人啪精品午夜网站| 亚洲精品在线观看二区| 18禁裸乳无遮挡免费网站照片| 亚洲av五月六月丁香网| 亚洲五月天丁香| 欧美激情久久久久久爽电影| 成人午夜高清在线视频| 日日摸夜夜添夜夜添av毛片 | 十八禁网站免费在线| 欧美国产日韩亚洲一区| 久久欧美精品欧美久久欧美| 精品欧美国产一区二区三| 一区二区三区高清视频在线| 一本一本综合久久| 我的老师免费观看完整版| 久久午夜亚洲精品久久| 国产老妇女一区| 国产精品久久久久久人妻精品电影| 老司机深夜福利视频在线观看| 丝袜美腿在线中文| 欧美乱色亚洲激情| 我要搜黄色片| 国内精品一区二区在线观看| 亚洲av第一区精品v没综合| 国产伦一二天堂av在线观看| 搡老妇女老女人老熟妇| 欧美精品啪啪一区二区三区| 69人妻影院| 欧美不卡视频在线免费观看| 噜噜噜噜噜久久久久久91| 中文资源天堂在线| 免费观看人在逋| 国产熟女xx| 久久久久久大精品| 亚洲av不卡在线观看| 国产真实伦视频高清在线观看 | 最近在线观看免费完整版| 在线a可以看的网站| 俺也久久电影网| 亚洲精品一卡2卡三卡4卡5卡| 欧美成人a在线观看| 99视频精品全部免费 在线| 成年人黄色毛片网站| 精品国产亚洲在线| 成年人黄色毛片网站| 12—13女人毛片做爰片一| 熟女人妻精品中文字幕| 午夜福利高清视频| 一级黄片播放器| 最好的美女福利视频网| 中出人妻视频一区二区| 婷婷色综合大香蕉| 国产久久久一区二区三区| 91麻豆精品激情在线观看国产| 日本一本二区三区精品| АⅤ资源中文在线天堂| 中文字幕av在线有码专区| 18禁在线播放成人免费| 欧美精品啪啪一区二区三区| 色播亚洲综合网| 在线观看免费视频日本深夜| 欧美成狂野欧美在线观看| 国产乱人视频| 成年免费大片在线观看| 国产一区二区在线观看日韩| 最近最新中文字幕大全电影3| 男女床上黄色一级片免费看| 午夜精品一区二区三区免费看| 麻豆国产97在线/欧美| 99久久99久久久精品蜜桃| 深爱激情五月婷婷| 亚洲国产精品合色在线| 欧美日韩乱码在线| 99久久九九国产精品国产免费| 毛片女人毛片| 麻豆久久精品国产亚洲av| 1024手机看黄色片| 色哟哟哟哟哟哟| 别揉我奶头~嗯~啊~动态视频| 亚洲 国产 在线| 性欧美人与动物交配| 一进一出好大好爽视频| 亚洲在线观看片| 国产黄a三级三级三级人| 看片在线看免费视频| 久久精品综合一区二区三区| 亚洲av中文字字幕乱码综合| 久久久久久大精品| 成人永久免费在线观看视频| 欧美zozozo另类| 不卡一级毛片| 亚洲人成电影免费在线| 亚洲成人久久性| 99精品久久久久人妻精品| 婷婷精品国产亚洲av在线| 亚洲精品456在线播放app | 熟女电影av网| 一个人观看的视频www高清免费观看| 波多野结衣巨乳人妻| 国产一区二区激情短视频| 午夜免费男女啪啪视频观看 | 亚洲国产高清在线一区二区三| 亚洲欧美日韩高清专用| 国产爱豆传媒在线观看| 久99久视频精品免费| 亚洲 国产 在线| 亚洲男人的天堂狠狠| 亚洲熟妇熟女久久| 欧美日韩国产亚洲二区| 日本 欧美在线| 久久久久久九九精品二区国产| 精品日产1卡2卡| www.999成人在线观看| 久久久久久久久久成人| 嫁个100分男人电影在线观看| 中文字幕av成人在线电影| 亚洲精品456在线播放app | 久久久久久久午夜电影| 欧美乱色亚洲激情| 99riav亚洲国产免费| 国产精品影院久久| 亚洲第一电影网av| 国产精品三级大全|